Open Access

Streptococcus pneumoniae is endowed with a variety of surface-exposed proteins representing putative vaccine candidates. Lipoproteins are covalently anchored to the cell membrane and highly conserved among pneumococcal serotypes. Here, we evaluated these lipoproteins for their immunogenicity and protective potential against pneumococcal colonisation. A multiplex-based immunoproteomics approach revealed the immunogenicity of selected lipoproteins. High antibody titres were measured in sera from mice immunised with the lipoproteins MetQ, PnrA, PsaA, and DacB. An analysis of convalescent patient sera confirmed the immunogenicity of these lipoproteins. Examining the surface localisation and accessibility of the lipoproteins using flow cytometry indicated that PnrA and DacB were highly abundant on the surface of the bacteria. Mice were immunised intranasally with PnrA, DacB, and MetQ using cholera toxin subunit B (CTB) as an adjuvant, followed by an intranasal challenge with S. pneumoniae D39. PnrA protected the mice from pneumococcal colonisation. For the immunisation with DacB and MetQ, a trend in reducing the bacterial load could be observed, although this effect was not statistically significant. The reduction in bacterial colonisation was correlated with the increased production of antigen-specific IL-17A in the nasal cavity. Immunisation induced high systemic IgG levels with a predominance for the IgG1 isotype, except for DacB, where IgG levels were substantially lower compared to MetQ and PnrA. Our results indicate that lipoproteins are interesting targets for future vaccine strategies as they are highly conserved, abundant, and immunogenic.

Preventive strategies involving the use of pneumococcal conjugate vaccines (PCVs) are known to drastically reduce pneumococcal disease. However, PCV vaccination has been plagued with serotype replacement by non-PCV serotypes. In this study, we describe the prevalence and molecular characteristics of non-PCV13 serotypes (non-vaccine serotypes, NVTs) from pneumococcal carriage isolates obtained from children < 5 years old in Cape Coast, Ghana, after PCV introduction. The isolates were subjected to antibiotic susceptibility testing and multilocus sequence typing (MLST), and molecular techniques were used to detect the presence of virulence genes. Serotypes 11A, 13, 15B, 23B, and 34 formed the top five of the 93 NVT isolates. As such, 20 (21.5%), 49 (48.4%), and 70 (74.3%) isolates were non-susceptible to penicillin, tetracycline, and cotrimoxazole, respectively. Sixteen (17.2%) multidrug-resistant isolates were identified. However, non-susceptibility to ceftriaxone and erythromycin was low and all isolates were fully susceptible to levofloxacin, linezolid, and vancomycin. Whereas pcpA, pavB, lytA, and psrP genes were detected in nearly all serotypes, pilus islet genes were limited to serotypes 11A, 13, and 23B. MLST for predominant serotype 23B isolates revealed three known and seven novel sequence types (STs). ST172 and novel ST15111 were the most dominant and both STs were related to PMEN clone Columbia23F-26 (ST338). In conclusion, non-PCV13 serotype 23B was the most prevalent, with characteristics of rapid clonal expansion of ST172 and ST15111, which are related to international clones of the pneumococcus. Continuous monitoring of NVTs in Ghana is, therefore, essential, as they have the potential to cause invasive disease, show high antibiotic resistance, and attenuate the effects of PCV vaccination.

Streptococcus pneumoniae (pneumococci) are lancet-shaped, Gram-positive, alpha-hemolytic, facultative anaerobic human specific commensals of the upper and lower respiratory tract. Pneumococci may convert to pathogenic bacteria and spread to the lungs and blood. In different population groups, such as children, the elderly and immunocompromised individuals, pneumococci can cause local infections such as bronchitis, rhinitis, acute sinusitis, and otitis media as well as life-threatening invasive diseases such as community-acquired pneumonia, sepsis and meningitis. Pneumococci are surrounded by a rigid and complex exoskeleton, the peptidoglycan, also referred to as murein sacculus. The peptidoglycan (PNG) protects the cells from rupture by osmotic pressure and maintains their characteristic shape. The PNG is a heteropolymer made up of glycan strands that are cross-linked by short peptides and during growth the existing murein is continuously hydrolyzed by specific lytic enzymes to enable the insertion of new peptidoglycan. Bacterial cell-wall hydrolases are essential for peptidoglycan turnover and crucial to preserve cell shape. The D,D-carboxypeptidase DacA and L,D-carboxypeptidase DacB of Streptococcus pneumoniae function in a sequential manner. This study determined the crystal structure of the surface-exposed lipoprotein DacB, which differs considerably from the DacA structure. DacB contains a Zn2+ ion in its catalytic center located in the middle of a fully exposed, large groove. Two different conformations with differently arranged active site topology were identified. In addition the critical residues for catalysis and substrate specificity were identified. Deficiency in DacA or DacB resulted in a modified peptidoglycan peptide composition and led to an altered cell shape of the dac-mutants. In contrast, lgt-mutant lacking lipoprotein diacylglyceryl transferase activity required for proper lipoprotein maturation retained L,D-carboxypeptidase activity and showed an intact murein sacculus. Furthermore, this study demonstrated the pathophysiological effects of disordered DacA or DacB activities. Real-time bioimaging of intranasally infected mice indicated a substantially attenuated virulence of dacB- and dacAdacB-mutants pneumococci, while loss of function of DacA had no significant effect. In addition, uptake of these mutants by professional phagocytes was enhanced, while their adherence to lung epithelial cells was decreased. The second part of this study focused on the functional and structure determination of the soluble dimeric pneumococcal lipoprotein PccL. Because of its calycin fold and structural homology with the lipocalin YxeF from Bacillus subtilis, PccL was introduced as the first member of the lipocalin protein family in pneumococci and named “PccL” (Pneumococcal calycin fold containing Lipoprotein). Similar to other lipocalins, the distinct beta-barrel, which is open at one end, is significantly conserved in PccL. Moreover, the application of the in vivo acute pneumonia mouse infection model and the in vitro phagocytosis as well as adherence invasion studies revealed considerable differences in colonization and invasive infection between the wild-type D39 and the pccL-mutant. In conclusion, this study characterized the crucial role of pneumococcal carboxypeptidases DacA and DacB for PGN architecture, bacterial shape and pathogenesis. By applying in vivo and in vitro approaches, a close relationship between PGN metabolism and pathophysiological effects was discovered. In addition, the high resolution structure of DacB has been solved and analyzed and a structure model with a resolution of 2.0 Å is provided. Furthermore, analysis of the PGN composition was applied to indicate the impact of an impaired lipoprotein biogenesis pathway on localization and activity of DacB. The major impact of carboxypeptidases on cell shape and virulence proposes DacB as a promising target for the development of novel drugs or due to its surface exposition also as a promising vaccine candidate. PccL is the first pneumococcal lipocalin-like protein and this study indicated its contribution to pneumococcal virulence. However, the mechanism and the mode of action of PccL are still unknown and have to be deciphered in further studies.